Effects and management of denosumab discontinuation

被引:16
作者
Chapurlat, Roland [1 ,2 ,3 ]
机构
[1] Hop Edouard Herriot, Serv Rhumatol & Pathol Osseuse, F-69437 Lyon 03, France
[2] INSERM, UMR 1033, F-69437 Lyon 03, France
[3] Univ Lyon, F-69437 Lyon 03, France
关键词
Osteoporosis; Fracture; Denosumab; Drug holiday; POSTMENOPAUSAL WOMEN; VERTEBRAL FRACTURES; BONE LOSS; OSTEOPOROSIS;
D O I
10.1016/j.jbspin.2017.12.013
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
引用
收藏
页码:515 / 517
页数:3
相关论文
共 20 条
[1]
Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research [J].
Adler, Robert A. ;
El-Hajj Fuleihan, Ghada ;
Bauer, Douglas C. ;
Camacho, Pauline M. ;
Clarke, Bart L. ;
Clines, Gregory A. ;
Compston, Juliet E. ;
Drake, Matthew T. ;
Edwards, Beatrice J. ;
Favus, Murray J. ;
Greenspan, Susan L. ;
McKinney, Ross, Jr. ;
Pignolo, Robert J. ;
Sellmeyer, Deborah E. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2016, 31 (01) :16-35
[2]
Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases [J].
Anastasilakis, Athanasios D. ;
Polyzos, Stergios A. ;
Makras, Polyzois ;
Aubry-Rozier, Berengere ;
Kaouri, Stella ;
Lamy, Olivier .
JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 (06) :1291-1296
[3]
Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports [J].
Aubry-Rozier, B. ;
Gonzalez-Rodriguez, E. ;
Stoll, D. ;
Lamy, O. .
OSTEOPOROSIS INTERNATIONAL, 2016, 27 (05) :1923-1925
[4]
A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women [J].
Bekker, PJ ;
Holloway, DL ;
Rasmussen, AS ;
Murphy, R ;
Martin, SW ;
Leese, PT ;
Holmes, GB ;
Dunstan, CR ;
DePaoli, AM .
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (07) :1059-1066
[5]
10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension [J].
Bone, Henry G. ;
Wagman, Rachel B. ;
Brandi, Maria L. ;
Brown, Jacques P. ;
Chapurlat, Roland ;
Cummings, Steven R. ;
Czerwinski, Edward ;
Fahrleitner-Pammer, Astrid ;
Kendler, David L. ;
Lippuner, Kurt ;
Reginster, Jean-Yves ;
Roux, Christian ;
Malouf, Jorge ;
Bradley, Michelle N. ;
Daizadeh, Nadia S. ;
Wang, Andrea ;
Dakin, Paula ;
Pannacciulli, Nicola ;
Dempster, David W. ;
Papapoulos, Socrates .
LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (07) :513-523
[6]
Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass [J].
Bone, Henry G. ;
Bolognese, Michael A. ;
Yuen, Chui Kin ;
Kendler, David L. ;
Miller, Paul D. ;
Yang, Yu-Ching ;
Grazette, Luanda ;
San Martin, Javier ;
Gallagher, J. Christopher .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (04) :972-980
[7]
Discontinuation of denosumab and associated fracture incidence: Analysis from the Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months (FREEDOM) Trial [J].
Brown, Jacques P. ;
Roux, Christian ;
Torring, Ove ;
Ho, Pei-Ran ;
Jensen, Jens-Erik Beck ;
Gilchrist, Nigel ;
Recknor, Christopher ;
Austin, Matt ;
Wang, Andrea ;
Grauer, Andreas ;
Wagman, Rachel B. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (04) :746-752
[8]
Bone Remodeling in Postmenopausal Women Who Discontinued Denosumab Treatment: Off-Treatment Biopsy Study [J].
Brown, Jacques P. ;
Dempster, David W. ;
Ding, Beiying ;
Dent-Acosta, Ricardo ;
San Martin, Javier ;
Grauer, Andreas ;
Wagman, Rachel B. ;
Zanchetta, Jose .
JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (11) :2737-2744
[9]
Brown JP, 2016, J BONE MINER RES, V31
[10]
Is it time for treat to target strategy in osteoporosis? [J].
Chapurlat, Roland .
JOINT BONE SPINE, 2016, 83 (04) :381-383